Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Ghezzi

Showing results (121-130 of 133) with videos related to

Pageof 14
Sort By:
BMC Neurology|October 24, 2012
Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric studyMarta Giannini, Emilio Portaccio, Angelo Ghezzi, et al.
Neurology|February 14, 2018
Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risksEmilio Portaccio, Pietro Annovazzi, Angelo Ghezzi, et al.
Neurology|April 19, 2022
Long-term Cognitive Outcomes and Socioprofessional Attainment in People With Multiple Sclerosis With Childhood OnsetEmilio Portaccio, Angelo Bellinvia, Lorenzo Razzolini, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 16, 2021
Pregnancy in multiple sclerosis women with relapses in the year before conception increases the risk of long-term disability worseningEmilio Portaccio, Laura Tudisco, Luisa Pastò, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 17, 2022
Natalizumab treatment and pregnancy in multiple sclerosis: A reappraisal of maternal and infant outcomes after 6 yearsEmilio Portaccio, Luisa Pastò, Lorenzo Razzolini, et al.
BMC Neurology|October 17, 2015
A comparison of the brief international cognitive assessment for multiple sclerosis and the brief repeatable battery in multiple sclerosis patientsClaudia Niccolai, Emilio Portaccio, Benedetta Goretti, et al.
Brain : a Journal of Neurology|September 13, 2015
Fingolimod versus interferon beta/glatiramer acetate after natalizumab suspension in multiple sclerosisPietro Iaffaldano, Giuseppe Lucisano, Carlo Pozzilli, et al.
Neurology and Therapy|February 18, 2026
Reducing Early-Life Smoke Exposure as a Preventive Strategy for Pediatric Multiple Sclerosis: Results from the PEDIGREE StudySilvy Pilotto, Angelo Ghezzi, Stefania Maria Bova, et al.
Brain : a Journal of Neurology|September 16, 2020
Disease-modifying drugs can reduce disability progression in relapsing multiple sclerosisMaria Pia Amato, Mattia Fonderico, Emilio Portaccio, et al.
Neurology and Therapy|May 24, 2026
Reduced Childhood Outdoor Exposure Raises Pediatric Multiple Sclerosis (PedMS) RiskSilvy Pilotto, Angelo Ghezzi, Stefania Maria Bova, et al.
Pageof 14

Showing results (121-130 of 133) with videos related to

Sort By:
Pageof 14
BMC Neurology|October 24, 2012
Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric studyMarta Giannini, Emilio Portaccio, Angelo Ghezzi, et al.
Neurology|February 14, 2018
Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risksEmilio Portaccio, Pietro Annovazzi, Angelo Ghezzi, et al.
Neurology|April 19, 2022
Long-term Cognitive Outcomes and Socioprofessional Attainment in People With Multiple Sclerosis With Childhood OnsetEmilio Portaccio, Angelo Bellinvia, Lorenzo Razzolini, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 16, 2021
Pregnancy in multiple sclerosis women with relapses in the year before conception increases the risk of long-term disability worseningEmilio Portaccio, Laura Tudisco, Luisa Pastò, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 17, 2022
Natalizumab treatment and pregnancy in multiple sclerosis: A reappraisal of maternal and infant outcomes after 6 yearsEmilio Portaccio, Luisa Pastò, Lorenzo Razzolini, et al.
BMC Neurology|October 17, 2015
A comparison of the brief international cognitive assessment for multiple sclerosis and the brief repeatable battery in multiple sclerosis patientsClaudia Niccolai, Emilio Portaccio, Benedetta Goretti, et al.
Brain : a Journal of Neurology|September 13, 2015
Fingolimod versus interferon beta/glatiramer acetate after natalizumab suspension in multiple sclerosisPietro Iaffaldano, Giuseppe Lucisano, Carlo Pozzilli, et al.
Neurology and Therapy|February 18, 2026
Reducing Early-Life Smoke Exposure as a Preventive Strategy for Pediatric Multiple Sclerosis: Results from the PEDIGREE StudySilvy Pilotto, Angelo Ghezzi, Stefania Maria Bova, et al.
Brain : a Journal of Neurology|September 16, 2020
Disease-modifying drugs can reduce disability progression in relapsing multiple sclerosisMaria Pia Amato, Mattia Fonderico, Emilio Portaccio, et al.
Neurology and Therapy|May 24, 2026
Reduced Childhood Outdoor Exposure Raises Pediatric Multiple Sclerosis (PedMS) RiskSilvy Pilotto, Angelo Ghezzi, Stefania Maria Bova, et al.
Pageof 14